Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment

QR Code

Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment

As a part of a randomized clinical trial, the potential of patients’ education and monitoring by ambulatory therapeutists for improving pharmaceutical prevention and treatment effectiveness in Type 2 diabetes mellitus (DM-2) was evaluated. After 12 months, patients’ compliance and lipid level contro...

Full description

Saved in:

Bibliographic Details
Main Author:	E. A. Palferova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2008-02-01
Series:	Российский кардиологический журнал
Subjects:	type 2 diabetes mellitus cardiovascular disease prevention treatment therapeutist ambulatory clinic
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic education of patients with Type 2 diabetes mellitus and high cardiovascular risk
by: E. A. Palferova, et al.
Published: (2007-12-01)

Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients
by: R. G. Oganov, et al.
Published: (2008-12-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

The death rate of patients with type 2 diabetes mellitus and impaired glucose tolerance from cardiovascular disease
by: E. A. Palferova
Published: (2005-04-01)

General characteristics and gender specifics of cardiovascular patients in ambulatory practice
by: I. V. Samorodskaya, et al.
Published: (1970-01-01)

CLINICAL STUDY OF OPTIMIZED APPROACHES TO LOCAL PREVENTION OF DENTAL CARIES IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
by: O.A. Udod, et al.
Published: (2019-09-01)

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2018-06-01)

Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting
by: Feyisa Assefa Dhaba, et al.
Published: (2025-07-01)

Treatment of Patients Chronic Coronary Heart Disease and Type 2 Diabetes Mellitus
by: E. V. Shсhukina, et al.
Published: (2023-04-01)

History of alternative preventive therapies for type 1 diabetes mellitus
by: T. S. Khobotkova, et al.
Published: (2025-02-01)

Clinical features analysis of fulminant type 1 diabetes mellitus
by: Min GAO, et al.
Published: (2025-06-01)

Effects of Pharmacist Chart Review and Pharmacist Interventions on Diabetes GAP Scores in the Rural Ambulatory Care Setting
by: Austin Steichen, et al.
Published: (2025-07-01)

ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS: AN INDIVIDUALIZED CHOICE OF ANTIHYPERTENSIVE MEDICATIONS
by: T. E. Morozova, et al.
Published: (2011-04-01)

Clinical Features of Urinary Infections in Pregnant Women with Type 1 Diabetes Mellitus
by: I. V. Alekseenko, et al.
Published: (2020-06-01)

Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older
by: L. A. Ratnikova, et al.
Published: (2012-08-01)

Vitamin B6, cardiovascular diseases, and diabetes mellitus
by: A.A. Serhiyenko, et al.
Published: (2025-03-01)

Developing a comprehensive structured program for managing gestational diabetes mellitus and preventing type 2 diabetes mellitus in Chinese women: a multi-method study
by: Jing Huang, et al.
Published: (2025-08-01)

Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases
by: Е. V. Shlyakhto, et al.
Published: (2018-09-01)

Pharmaceutical and non-pharmaceutical antihypertensive therapy in Type 2 diabetes mellitus patients
by: S. G. Malishevsky
Published: (2006-04-01)

Preparation of patients with type 2 diabetes mellitus for elective percutaneous coronary intervention
by: A. M. Kochergina, et al.
Published: (2023-09-01)

The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus
by: T. Yu. Demidova, et al.
Published: (2020-09-01)

ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure
by: I. E. Chazova
Published: (2008-04-01)

Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
by: O.M. Bilovol, et al.
Published: (2021-06-01)

Type 2 Diabetes Mellitus and Cognitive Impairment
by: Johanda Damanik, et al.
Published: (2021-07-01)

Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus
by: Muhammad Syah Abdaly, et al.
Published: (2019-08-01)

Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus
by: Muhammad Syah Abdaly, et al.
Published: (2019-08-01)

Association Between Glycated Hemoglobin and Diabetic Retinopathy in Individuals with Diabetes: A Focus on the Modifying Effect of Ambulatory Blood Pressure
by: Yang S, et al.
Published: (2025-07-01)

Organisational technologies for ambulatory outpatient healthcare quality improvement in cardiovascular disease patients
by: L. S. Barbarash, et al.
Published: (2009-08-01)

Prevention of gestational diabetes mellitus
by: N. V. Artymuk, et al.
Published: (2023-09-01)

Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study
by: Xiang Zhao, et al.
Published: (2025-07-01)

SYSTEM FOR THE NEAREST CARDIOVASCULAR RISK ASSESSMENT IN SECOND TYPE DIABETES PATIENTS
by: N. V. Leonova, et al.
Published: (2016-04-01)

ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK
by: M. N. Kovrigina, et al.
Published: (2015-12-01)

Sociodemographic, health and behavioral factors associated with influenza vaccination uptake among patients with diabetes in Singapore: A cohort registry-based study
by: Siang Joo Seah, et al.
Published: (2025-08-01)

FACTORS ASSOCIATED WITH THE DEVELOPMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH TYPE 1 DIABETES MELLITUS WITH DIABETIC NEPHROPATHY
by: Ye. A. Khantakova
Published: (2014-04-01)

Sex‐ and age‐specific effect of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population‐based Heinz Nixdorf Recall study
by: Anna Lena Platzbecker, et al.
Published: (2025-04-01)

BETA-ADRENOBLOCKER THERAPY IN ARTERIAL HYPERTENSION, METABOLIC DISTURBANCES, AND TYPE 2 DIABETES MELLITUS
by: D. V. Nebieridze, et al.
Published: (2009-08-01)

CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
by: I. E. Sapozhnikova, et al.
Published: (2016-01-01)

Effectiveness and Safety of DLBS3233 in Newly Diagnosed Type 2 Diabetes Mellitus: A 12-week Clinical Trial
by: Heri Nugroho, et al.
Published: (2024-10-01)

Knowledge, Attitude, And Practice in Diabetic Kidney Disease Prevention and Its Associated Factor Among Type 2 Diabetes Mellitus Patients in Northeast Peninsular Malaysia
by: Anas Bin Rosedi, et al.
Published: (2025-07-01)

PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE
by: M. N. Mamedov, et al.
Published: (2015-12-01)